Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-08

Clinical Trial Update: Exparel Infiltration in Anterior Cruciate Ligament Reconstruction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Exparel infiltration used in anterior cruciate ligament reconstruction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: Henry Ford Health System | Conditions: Pain | Phase 4 | Status: COMPLETED